Estrogen receptor antagonists bind to estrogen receptors and inhibit the action of estrogen. Estrogen controls the growth of certain types of breast cancers called estrogen receptor positive cancers. So estrogen receptor antagonists are useful in treating patients with estrogen sensitive breast cancers.
Name | Updated |
---|---|
Orserdu (Elacestrant) | 05-Aug-2023 |
Fulvestrant (Fulvestrant) | 10-Jul-2023 |
Faslodex (Fulvestrant [ ful-ves-trant ]) | 10-Jul-2023 |